ARCA biopharma Inc. (ABIO)
Symbol Info
Listed Symbol ABIO
Name ARCA biopharma Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2016-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-10.13
Price Info
21 Day Moving Average $5.4900
21 Day EMA $5.402320
50 Day Moving Average $5.6105
50 Day EMA $5.718990
200 Day EMA $7.300750
200 Day Moving Average 6.885110
52 Week High $20.45
52 Week Low $4.73
52 Week Change $-49.198402
Alpha -0.046509
Beta 1.8580
Standard Deviation 0.196250
R2 0.105815
Periods 60
Share Information
10 Day Average Volume 25,925
20 Day Average Volume 34,982
30 Day Average Volume 114,423
50 Day Average Volume 92,238
Outstanding Shares 1,455,556
Float Shares 1,033,133
Percent Float 70.98%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 25
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months -
Institute Holdings Percent 19.300000
Institute Sold Previous 3 Months -
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months -
Insider Holdings Percent 29.00%
Insider Sold Previous 3 Months -
Insiders Shares Owned 422,423
Price Change
7 Day Price Change $0.0200000
7 Day Percent Change 0.39%
21 Day Price Change $-0.4900003
21 Day Percent Change -8.70%
30 Day Price Change $-1.31
30 Day Percent Change -20.31%
Month To Date Price Change $-0.2099
Month To Date Percent -3.92%
90 Day Price Change $-1.73
90 Day Percent Change -25.18%
Quarter To Date $-0.2099
Quarter To Date Percent -3.92%
180 Day Price Change $-0.58
180 Day Percent Change -10.14%
200 Day Price Change $-1.637
200 Day Percent Change -24.16%
Year To Date $-0.863
Year To Date Percent -14.38%
Profile
Description
Details
Issue Type CS
Market Cap $7,481,558
Sec Type EQS
Auditor KPMG LLP
Total Shares Outstanding 1,455,556
CEO Michael R. Bristow
Employees 20
Last Audit UE
Classification
CIK 0000907654
Industry Biotechnology
Sector Healthcare
NAICS In-Vitro Diagnostic Substance Manufacturing(325413)
Info
Address 11080 CirclePoint Road
Suite 140
Westminster, CO 80020
Website http://www.arcabiopharma.com
Facisimile
Telephone +1 720 940-2200
Email derek.cole@arcabio.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $-2,178,921
Price To Sales -
Price To Free Cash -1.8
PE High Last 5 Years -
Price To Book 0.8
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 0.8
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 9.0
Leverage Ratio 1.1
Quick Ratio 8.8
Long Term Debt To Capital -
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -52.21
Return On Equity -55.65
Return On Capital -46.1
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
ABIO
ARCA Bioph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.